Diabetes Associated Ophthalmic Treatment Market Size, Share, Growth 2034
Diabetes Associated Ophthalmic Treatment Market By Type (Devices and Drugs), By Application (Diabetes Retinopathy, Glaucoma, Cataract, Dry Eye Syndrome, Diabetes Associated Macular Degeneration, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 213 Report Code: ZMR-9536
Published Date: Jun-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 35.45 Billion | USD 69.09 Billion | 6.90% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Diabetes Associated Ophthalmic Treatment Market, (2025 - 2034) (USD Billion )
- 2.2 Global Diabetes Associated Ophthalmic Treatment Market : snapshot
- Chapter 3. Global Diabetes Associated Ophthalmic Treatment Market - Industry Analysis
- 3.1 Diabetes Associated Ophthalmic Treatment Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing number of diabetic patients worldwide to propel market expansion rate
- 3.3 Market Restraints
- 3.3.1. High cost of treatment to emerge as the crucial growth restraining factor
- 3.4 Market Opportunities
- 3.4.1. Increasing rate of innovation and new drug development to generate growth opportunities
- 3.5 Market Challenges
- 3.5.1. Patient compliance and side effects of the treatment to challenge market expansion
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Type
- 3.7.2 Market attractiveness analysis By Application
- Chapter 4. Global Diabetes Associated Ophthalmic Treatment Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Diabetes Associated Ophthalmic Treatment Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Diabetes Associated Ophthalmic Treatment Market - Type Analysis
- 5.1 Global Diabetes Associated Ophthalmic Treatment Market overview: By Type
- 5.1.1 Global Diabetes Associated Ophthalmic Treatment Market share, By Type, 2024 and 2034
- 5.2 Devices
- 5.2.1 Global Diabetes Associated Ophthalmic Treatment Market by Devices, 2025 - 2034 (USD Billion )
- 5.3 Drugs
- 5.3.1 Global Diabetes Associated Ophthalmic Treatment Market by Drugs, 2025 - 2034 (USD Billion )
- 5.1 Global Diabetes Associated Ophthalmic Treatment Market overview: By Type
- Chapter 6. Global Diabetes Associated Ophthalmic Treatment Market - Application Analysis
- 6.1 Global Diabetes Associated Ophthalmic Treatment Market overview: By Application
- 6.1.1 Global Diabetes Associated Ophthalmic Treatment Market share, By Application, 2024 and 2034
- 6.2 Diabetes Retinopathy
- 6.2.1 Global Diabetes Associated Ophthalmic Treatment Market by Diabetes Retinopathy, 2025 - 2034 (USD Billion )
- 6.3 Glaucoma
- 6.3.1 Global Diabetes Associated Ophthalmic Treatment Market by Glaucoma, 2025 - 2034 (USD Billion )
- 6.4 Cataract
- 6.4.1 Global Diabetes Associated Ophthalmic Treatment Market by Cataract, 2025 - 2034 (USD Billion )
- 6.5 Dry Eye Syndrome
- 6.5.1 Global Diabetes Associated Ophthalmic Treatment Market by Dry Eye Syndrome, 2025 - 2034 (USD Billion )
- 6.6 Diabetes Associated Macular Degeneration
- 6.6.1 Global Diabetes Associated Ophthalmic Treatment Market by Diabetes Associated Macular Degeneration, 2025 - 2034 (USD Billion )
- 6.7 Others
- 6.7.1 Global Diabetes Associated Ophthalmic Treatment Market by Others, 2025 - 2034 (USD Billion )
- 6.1 Global Diabetes Associated Ophthalmic Treatment Market overview: By Application
- Chapter 7. Diabetes Associated Ophthalmic Treatment Market - Regional Analysis
- 7.1 Global Diabetes Associated Ophthalmic Treatment Market Regional Overview
- 7.2 Global Diabetes Associated Ophthalmic Treatment Market Share, by Region, 2024 & 2034 (USD Billion )
- 7.3. North America
- 7.3.1 North America Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.3.1.1 North America Diabetes Associated Ophthalmic Treatment Market, by Country, 2025 - 2034 (USD Billion )
- 7.3.1 North America Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.4 North America Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034
- 7.4.1 North America Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034 (USD Billion )
- 7.5 North America Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034
- 7.5.1 North America Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034 (USD Billion )
- 7.4. Europe
- 7.4.2 Europe Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.4.2.1 Europe Diabetes Associated Ophthalmic Treatment Market, by Country, 2025 - 2034 (USD Billion )
- 7.4.2 Europe Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.4 Europe Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034
- 7.4.1 Europe Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034 (USD Billion )
- 7.5 Europe Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034
- 7.5.1 Europe Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034 (USD Billion )
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.5.3.1 Asia Pacific Diabetes Associated Ophthalmic Treatment Market, by Country, 2025 - 2034 (USD Billion )
- 7.5.3 Asia Pacific Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.4 Asia Pacific Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034
- 7.4.1 Asia Pacific Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034 (USD Billion )
- 7.5 Asia Pacific Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034
- 7.5.1 Asia Pacific Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034 (USD Billion )
- 7.6. Latin America
- 7.6.4 Latin America Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.6.4.1 Latin America Diabetes Associated Ophthalmic Treatment Market, by Country, 2025 - 2034 (USD Billion )
- 7.6.4 Latin America Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.4 Latin America Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034
- 7.4.1 Latin America Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034 (USD Billion )
- 7.5 Latin America Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034
- 7.5.1 Latin America Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034 (USD Billion )
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.7.5.1 The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, by Country, 2025 - 2034 (USD Billion )
- 7.7.5 The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 7.4 The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034
- 7.4.1 The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, by Type, 2025 - 2034 (USD Billion )
- 7.5 The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034
- 7.5.1 The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, by Application, 2025 - 2034 (USD Billion )
- Chapter 8. Company Profiles
- 8.1 Pfizer Inc.
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 F. Hoffmann-La Roche Ltd
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Bausch Health Companies Inc.
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 EyePoint Pharmaceuticals Inc.
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Johnson & Johnson Services Inc.
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Kodiak Sciences Inc.
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Santen Pharmaceutical Co. Ltd.
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Ocular Therapeutix Inc.
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Novartis AG
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Genentech Inc.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 AbbVie Inc.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Oxurion NV
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Bayer AG
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 Regeneron Pharmaceuticals Inc.
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 Alcon Inc.
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 and others.
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.1 Pfizer Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 4. Porter’s Five Forces Analysis
- 5. Global Diabetes Associated Ophthalmic Treatment Market attractiveness, By Type
- 6. Global Diabetes Associated Ophthalmic Treatment Market attractiveness, By Application
- 7. Global Diabetes Associated Ophthalmic Treatment Market share by Type, 2025 and 2034 (USD Billion )
- 8. Global Diabetes Associated Ophthalmic Treatment Market by Devices, 2025 - 2034 (USD Billion )
- 9. Global Diabetes Associated Ophthalmic Treatment Market by Drugs, 2025 - 2034 (USD Billion )
- 10. Global Diabetes Associated Ophthalmic Treatment Market share by Application, 2025 and 2034 (USD Billion )
- 11. Global Diabetes Associated Ophthalmic Treatment Market by Diabetes Retinopathy, 2025 - 2034 (USD Billion )
- 12. Global Diabetes Associated Ophthalmic Treatment Market by Glaucoma, 2025 - 2034 (USD Billion )
- 13. Global Diabetes Associated Ophthalmic Treatment Market by Cataract, 2025 - 2034 (USD Billion )
- 14. Global Diabetes Associated Ophthalmic Treatment Market by Dry Eye Syndrome, 2025 - 2034 (USD Billion )
- 15. Global Diabetes Associated Ophthalmic Treatment Market by Diabetes Associated Macular Degeneration, 2025 - 2034 (USD Billion )
- 16. Global Diabetes Associated Ophthalmic Treatment Market by Others, 2025 - 2034 (USD Billion )
- 17. Global Diabetes Associated Ophthalmic Treatment Market share, by Region, 2025 and 2034
- 18. North America Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 19. Europe Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 20. Asia Pacific Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 21. Latin America Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
- 22. The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market, 2025 - 2034 (USD Billion )
Table Of Tables
- 1. Global Diabetes Associated Ophthalmic Treatment Market: Snapshot
- 2. Drivers of the Diabetes Associated Ophthalmic Treatment Market: impact analysis
- 3. North America Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 4. North America Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 5. U.S. Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 6. U.S. Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 7. Canada Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 8. Canada Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 9. Europe Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 10. Europe Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 11. Germany Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 12. Germany Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 13. France Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 14. France Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 15. U.K. Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 16. U.K. Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 17. Italy Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 18. Italy Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 19. Spain Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 20. Spain Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 21. Rest of Europe Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 22. Rest of Europe Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 23. Asia Pacific Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 24. Asia Pacific Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 25. China Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 26. China Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 27. Japan Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 28. Japan Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 29. India Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 30. India Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 31. South Korea Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 32. South Korea Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 33. South-East Asia Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 34. South-East Asia Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 35. Rest of Asia Pacific Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 36. Rest of Asia Pacific Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 37. Latin America Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 38. Latin America Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 39. Brazil Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 40. Brazil Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 41. Mexico Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 42. Mexico Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 43. Rest of Latin America Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 44. Rest of Latin America Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 45. The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 46. The Middle-East and Africa Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 47. GCC Countries Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 48. GCC Countries Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 49. South Africa Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 50. South Africa Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
- 51. Rest of Middle-East Africa Diabetes Associated Ophthalmic Treatment Market revenue, By Type, 2025 - 2034 (USD Billion )
- 52. Rest of Middle-East Africa Diabetes Associated Ophthalmic Treatment Market revenue, By Application, 2025 - 2034 (USD Billion )
Methodology
FrequentlyAsked Questions
Diabetes associated ophthalmic treatment refers to a wide range of medical therapies, treatments, and care procedures undertaken to manage vision problems caused or amplified by diabetes.
The global diabetes associated ophthalmic treatment market is expected to be led by an increasing number of diabetic patients globally.
According to study, the global diabetes associated ophthalmic treatment market size was worth around USD 35.45 billion in 2024 and is predicted to grow to around USD 69.09 billion by 2034.
What will be the CAGR value of the diabetes associated ophthalmic treatment market during 2025-2034?
The CAGR value of diabetes associated ophthalmic treatment market is expected to be around 6.90% during 2025-2034.
The global diabetes associated ophthalmic treatment market will be led by Asia-Pacific during the forecast period.
The global diabetes associated ophthalmic treatment market is led by players like Pfizer Inc., F. Hoffmann-La Roche Ltd, Bausch Health Companies Inc., EyePoint Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Kodiak Sciences Inc., Santen Pharmaceutical Co., Ltd., Ocular Therapeutix, Inc., Novartis AG, Genentech, Inc., AbbVie Inc., Oxurion NV, Bayer AG, Regeneron Pharmaceuticals, Inc. and Alcon Inc.
The report explores crucial aspects of the diabetes associated ophthalmic treatment market, including a detailed discussion of existing growth factors and restraints, while browsing future growth opportunities and challenges that impact the market.
Choose License Type
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed